VRPX
Morgan Stanley’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-499
| Closed | -$190 | – | 8344 |
|
|
2024
Q4 | $190 | Buy |
499
+484
| +3,227% | +$184 | ﹤0.01% | 7418 |
|
|
2024
Q3 | $10 | Hold |
15
| – | – | ﹤0.01% | 7869 |
|
|
2024
Q2 | $8 | Hold |
15
| – | – | ﹤0.01% | 7793 |
|
|
2024
Q1 | $64 | Sell |
15
-285
| -95% | -$1.22K | ﹤0.01% | 7437 |
|
|
2023
Q4 | $96 | Buy |
300
+150
| +100% | +$48 | ﹤0.01% | 7485 |
|
|
2023
Q3 | $120 | Hold |
150
| – | – | ﹤0.01% | 7431 |
|
|
2023
Q2 | $162 | Hold |
150
| – | – | ﹤0.01% | 7467 |
|
|
2023
Q1 | $118 | Sell |
150
-926
| -86% | -$728 | ﹤0.01% | 7559 |
|
|
2022
Q4 | $669 | Buy |
1,076
+10
| +0.9% | +$6 | ﹤0.01% | 7527 |
|
|
2022
Q3 | $1K | Sell |
1,066
-16,950
| -94% | -$15.9K | ﹤0.01% | 7631 |
|
|
2022
Q2 | $30K | Sell |
18,016
-60,495
| -77% | -$101K | ﹤0.01% | 6841 |
|
|
2022
Q1 | $174K | Buy |
78,511
+73,619
| +1,505% | +$163K | ﹤0.01% | 5997 |
|
|
2021
Q4 | $16K | Buy |
4,892
+2,667
| +120% | +$8.72K | ﹤0.01% | 7310 |
|
|
2021
Q3 | $11K | Buy |
2,225
+1,509
| +211% | +$7.46K | ﹤0.01% | 7296 |
|
|
2021
Q2 | $3K | Buy |
+716
| New | +$3K | ﹤0.01% | 7498 |
|